Tardiferon

Leaflet attached to the packaging: patient information

Warning! Keep the leaflet, the information on the immediate packaging is in a foreign language.

Tardyferon, 80 mg of iron(II) ions, prolonged-release tablets

Ferrous sulfate

Read the leaflet carefully before taking the medicine, as it contains important information for the patient.

• Keep this leaflet, so you can read it again if you need to.
• If you have any doubts, consult your doctor or pharmacist.
• This medicine has been prescribed specifically for you. Do not give it to others. The medicine may harm another person, even if their symptoms are the same.
• If the patient experiences any side effects, including any side effects not listed in this leaflet, they should tell their doctor, pharmacist, or nurse. See section 4.

Table of contents of the leaflet

• 1. What is Tardyferon and what is it used for
• 2. Important information before taking Tardyferon
• 3. How to take Tardyferon
• 4. Possible side effects
• 5. How to store Tardyferon
• 6. Contents of the packaging and other information

1. What is Tardyferon and what is it used for

The need for iron is increased in women during pregnancy, postpartum, breastfeeding, and in adolescents during growth. Iron deficiency or iron deficiency anemia can be prevented or treated with Tardyferon.
In combination with iron and auxiliary substances, Fe ions are released slowly, which allows avoiding the sudden absorption of the entire iron dose into the blood serum.
This reduces the number of observed side effects and makes it easier for the patient to follow the recommendations. The slow release of the medicine allows iron ions to reach the final sections of the intestine, which, in addition to the duodenum, have the ability to absorb iron. The limitation of iron absorption to the upper segments of the intestine is caused by the iron saturation process. Like all iron-containing medicines, Tardyferon has no effect on erythropoiesis (red blood cell production) or anemia caused by factors other than iron deficiency.
Tardyferon is used to treat iron deficiency anemia and prevent iron deficiency in pregnant women with insufficient dietary intake.
Tardyferon is indicated for use in children over 10 years old and adults.

2. Important information before taking Tardyferon

When not to take Tardyferon

Warnings and precautions

Before starting to take Tardyferon, discuss it with your doctor or pharmacist.
The toxic dose of iron is lower for children than for adults. It is not recommended to give Tardyferon to children under 10 years old.
Iron deficiency supplementation should be, if possible, combined with treatment of the cause of the deficiency.
If the tablet gets into the airways, patients, especially the elderly and those with swallowing difficulties, may also be at risk of throat ulcers, esophageal ulcers, or bronchial ulcers. Bronchial necrosis (tissue death) or granuloma (inflammation) can lead to bronchial stenosis (narrowing of the airways). In case of improper swallowing, you should immediately contact a doctor or the nearest emergency department for proper treatment.
In medical literature, in elderly patients with chronic kidney disease, diabetes (high blood sugar), and (or) hypertension (high blood pressure) treated with several medications for these diseases and receiving iron supplementation due to accompanying anemia, gastrointestinal melanosis (discoloration of the gastrointestinal tract) has been described.

Children and adolescents

Tardyferon can be used in children over 10 years old.

Tardyferon and other medicines

Do not take Tardyferon unless your doctor decides to.
Some medicines cannot be taken at the same time, while others require special changes (e.g., time of administration):
It is recommended to avoid taking Tardyferon if the patient is taking iron-containing injections.
The following medicines may require a dose adjustment. Do not take Tardyferon within 2 hours of taking any of the following medicines:

• certain antibiotics (tetracyclines or fluoroquinolones);
• medicines used to treat weak bones (bisphosphonates);
• a medicine used to treat joint diseases (penicillamine);
• medicines used to treat excess stomach acid: mineral preparations acting on the gastrointestinal tract, charcoal, or antacids (aluminum, calcium, and magnesium salts);
• a medicine used to treat thyroid disease (thyroxine);
• a medicine used to treat Parkinson's disease (methyldopa, levodopa, carbidopa;
• supplements and (or) medicines containing zinc or calcium;
• cholestyramine - Tardyferon should be taken 1-2 hours before or 4 to 6 hours after cholestyramine;
• NSAIDs (nonsteroidal anti-inflammatory drugs) - they should be taken with food to reduce irritation of the stomach and intestinal mucosa and lower the risk of bleeding associated with their use.

If the patient is currently taking or has recently taken another medicine that is available without a prescription, they should tell their doctor or pharmacist.

Tardyferon with food, drink, and alcohol

Consuming large amounts of coffee, tea, or red wine may reduce iron absorption. It is not recommended to take this medicine at the same time as whole grain products (bran, legumes, oilseeds), some proteins (eggs), or foods and drinks containing calcium (cheese, milk, etc.). There should be a gap between taking iron salts and these foods (at least 2 hours).

Pregnancy, breastfeeding, and fertility

If the patient is pregnant or breastfeeding, thinks they may be pregnant, or plans to have a child, they should consult their doctor or pharmacist before taking this medicine.
Tardyferon can be used during pregnancy and breastfeeding.

Driving and using machines

It is unlikely that Tardyferon will affect the ability to drive and use machines.

3. How to take Tardyferon

This medicine should always be taken as directed by your doctor or pharmacist. If you have any doubts, consult your doctor or pharmacist.
Tardyferon is indicated for children over 10 years old and adults. The medicine is taken orally.
Treatment of iron deficiency anemia
Children over 10 years old and adults: 1 to 2 tablets per day.
The duration of treatment should be long enough to correct anemia and replenish iron stores.
Treatment may last at least 3 to 6 months and can be extended if necessary in agreement with the doctor.
Preventive treatment

• Latent iron deficiency: 1 tablet (corresponding to 80 mg of Fe) per day or every other day.
• Pregnant women: 1 tablet every other day during the last two trimesters of pregnancy (or from the 4th month of pregnancy).

Tardyferon tablets are taken orally.
The tablet should be swallowed whole, with a glass of water. Do not suck, chew, or hold it in your mouth.
Tablets should be taken with a large glass of water, preferably before or during a meal, depending on gastrointestinal tolerance (except for specific foods listed in the "Tardyferon with food, drink, and alcohol" section).

Taking a higher dose of Tardyferon than recommended

Cases of iron salt overdose have been reported, especially in children due to swallowing a large amount of medicine.
Symptoms of overdose include signs of gastrointestinal irritation with accompanying abdominal pain, nausea, vomiting, diarrhea, symptoms of cardiovascular shock or metabolic acidosis (rapid or shallow breathing, rapid heartbeat, headache, confusion, drowsiness, fatigue, loss of appetite), and liver and kidney failure.
If you have taken too much medicine, you should immediately contact the emergency department for proper treatment.

Missing a dose of Tardyferon

If you miss a dose at the usual time, take it as soon as possible. However, if it is close to the time for the next dose, do not take the missed dose and take the next tablet as usual.
Do not take a double dose to make up for the missed dose.
If you have any further doubts about taking this medicine, consult your doctor or pharmacist.

Stopping Tardyferon treatment

Tardyferon should be taken for as long as your doctor recommends. If you stop the treatment too early, the condition may recur.
If you have any further doubts about taking this medicine, consult your doctor or pharmacist.

4. Possible side effects

Like all medicines, Tardyferon can cause side effects, although not everybody gets them.
The following side effects may occur, listed in order of decreasing frequency:

Common (occurring in 1 to 10 patients)

Constipation, diarrhea, feeling of stomach fullness, abdominal pain, dark stool color, nausea.

Uncommon (occurring in less than 1 in 100 patients)

Throat swelling (laryngeal edema), abnormal stools, discomfort and pain in the upper abdomen (dyspepsia), vomiting, acute gastritis, itching, red rash (erythematous rash).

Frequency not known (cannot be estimated from the available data)

Allergic reaction (hypersensitivity reaction), rash with itching (urticaria), pulmonary necrosis (tissue death)*, pulmonary granuloma (inflammatory condition)*, bronchial stenosis (narrowing of the airways)*, tooth discoloration**, oral ulcers**, changes in the esophagus*, gastrointestinal melanosis (discoloration of the gastrointestinal tract)*.
*Patients, especially the elderly and those with swallowing difficulties, may also be at risk of throat ulcers, esophageal ulcers, or bronchial ulcers if the tablet gets into the airways. Pulmonary necrosis (tissue death) or granuloma (inflammatory condition) can lead to bronchial stenosis (narrowing of the airways). In case of improper administration, you should immediately contact a doctor or the nearest emergency department for proper treatment.
**In case of improper administration, when tablets are chewed, sucked, or held in the mouth.
In medical literature, in elderly patients with chronic kidney disease, diabetes (high blood sugar), and (or) hypertension (high blood pressure) treated with several medications for these diseases and receiving iron supplementation due to accompanying anemia, gastrointestinal melanosis (discoloration of the gastrointestinal tract) has been described.

Reporting side effects

If you experience any side effects, including any side effects not listed in the leaflet, you should tell your doctor, pharmacist, or nurse. Side effects can be reported directly to the Department of Monitoring of Adverse Reactions to Medicinal Products of the Office for Registration of Medicinal Products, Medical Devices, and Biocidal Products:
Jerozolimskie Avenue 181C, 02-222 Warsaw, phone: (+48) 22 49 21 301, fax: (+48) 22 49 21 309, website: https://smz.ezdrowie.gov.pl.
Side effects can also be reported to the marketing authorization holder or parallel importer.
Reporting side effects will help gather more information on the safety of the medicine.

5. How to store Tardyferon

The medicine should be stored out of sight and reach of children.
Do not use this medicine after the expiration date stated on the packaging. The expiration date is the last day of the specified month.
There are no special precautions for storing the medicine.
Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines that are no longer needed. This will help protect the environment.

6. Contents of the packaging and other information

What Tardyferon contains

• The active substance of the medicine is iron(II) in the form of iron(II) sulfate, dried 247.25 mg, which corresponds to a dose of 80 mg of iron(II) ions.
• The other ingredients are: maltodextrin, microcrystalline cellulose, ammonio methacrylate copolymer (type A) (Eudragit RL 30D), ammonio methacrylate copolymer (type B) (Eudragit RS 30D), triethyl citrate, talc, glycerol dibehenate. The composition of the coating: Sepifilm LP010 (hypromellose, microcrystalline cellulose, stearic acid), triethyl citrate, iron oxide red (E 172), iron oxide yellow (E 172), titanium dioxide (E 171).

What Tardyferon looks like and what the packaging contains

30 tablets in a cardboard box.
For more detailed information, please contact the marketing authorization holder or parallel importer.

Marketing authorization holder in Spain, the country of export:

Pierre Fabre Iberica, S.A.
Ramón Trias Fargas, 7-11
08005 Barcelona
Spain

Manufacturer:

Pierre Fabre Médicament Production
PROGIPHARM site
Rue du Lycée, 45500 Gien, France

Parallel importer:

Polypharm S.A.
Barska 33
02-315 Warsaw

Repackaged by:

CEFEA Sp. z o.o. Sp. komandytowa
Działkowa 56
02-234 Warsaw

Marketing authorization number in Spain, the country of export: 672908.3

Parallel import authorization number: 88/23 Date of approval of the leaflet: 19.05.2023

[Information about the trademark]